Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)
神经科学临床试验卓越网络(匹兹堡大学 CRS)
基本信息
- 批准号:10163275
- 负责人:
- 金额:$ 31.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvisory CommitteesAgreementBenchmarkingChildhoodClinicalClinical DataClinical InvestigatorClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommunitiesCommunity OutreachCommunity PhysicianData Coordinating CenterEnrollmentFosteringGoalsHealthcareInfrastructureInstitutesInstitutionInstitutional Review BoardsInterventionLeadershipMarylandMedical centerMissionModelingMonitorNational Institute of Neurological Disorders and StrokeNeurologicNeurosciencesOhioParticipantPatient CarePatientsPediatric NeurologyPennsylvaniaPerformancePhysiciansProgram DevelopmentProviderReportingResearchResearch PersonnelResearch TrainingResourcesRunningSiteStandardizationStructureSupport GroupsTimeLineTrainingTraining ProgramsTranslatingTranslational ResearchTranslationsUniversitiesWest VirginiaWorkbasecareercareer developmentclinical careclinical practiceclinical research sitecommunity clinicexperiencefollow-upinnovationmeetingsmembernervous system disorderoutreachoutreach programpatient registryperformance sitepre-clinicalprogramsrecruitsuccesstherapeutic developmentworking group
项目摘要
To translate the rapid progress in neurological therapeutic developments to patient care, clinical trials must keep pace with preclinical discoveries. Hurdles encountered in neuroscience clinical trials include delays in regulatory approvals, slow recruitment, participants lost to follow-up and slow translation of findings to clinical practice. The University of Pittsburgh has unique and significant resources and a proven track record of excellent performance in clinical trials, and in NeuroNEXT in particular. The aims of the proposed NINDS Network of Excellence in Neuroscience Trials at the University of Pittsburgh (NEXT-UP) are: (1) to develop an administrative structure to rapidly implement NeuroNEXT trials across of wide range of neurological conditions; (2) to foster collaboration and outreach in NeuroNEXT trials among academic physicians, community physicians, patients and patient support groups; and (3) to promote careers in clinical trial research by integrating clinical research training of early-stage investigators with NEXT-UP activities. The NEXT-UP leadership plan reflects these goals with a Program Director (Paula R. Clemens, MD) and co-Program Director (Lawrence R. Wechsler, MD); an Advisory Committee incorporating expertise and liaison to adult and pediatric neurology clinicians and patients; an early stage investigator; and a Program Coordinator. Collaboration will be established by meeting regularly and outreach to providers and the community. Recruitment will occur through high-volume referral providers and community outreach. Efficiency and monitoring will be accomplished through use of a central IRB and standardized trial agreements; establishing a timeline and benchmarks for each trial; monthly reports to the NEXT-UP Leadership from co-Investigators; and Corrective Action plans for challenges encountered. Promotion of careers in clinical trial research will include a training plan for early stage clinical neuroscience investigators. The combination of the University of Pittsburgh Medical Center's regional dominance in healthcare and this innovative proposal will allow NEXT-UP to continue to be a model site in the NeuroNEXT network with efficiently run clinical trials integrating investigators with community providers, patients and trainees.
为了将神经系统治疗发展的快速进步转化为患者护理,临床试验必须与临床前的发现保持同步。神经科学临床试验中遇到的障碍包括监管部门批准的延迟,缓慢的招聘,参与者失去了随访以及对临床实践的发现缓慢的转化。匹兹堡大学拥有独特而大量的资源,并在临床试验中,尤其是在Neuronext中表现出色的良好表现记录。匹兹堡大学(下一步)拟议的NINDS神经科学试验卓越卓越网络的目的是:(1)开发一种行政结构,以在广泛的神经系统状况中快速实施神经网络试验; (2)在学术医师,社区医生,患者和患者支持小组中,在神经网络试验中培养和宣传; (3)通过将早期研究人员的临床研究培训与下一个活动相结合,以促进临床试验研究的职业。下一个领导计划与计划主任(Paula R. Clemens,MD)和联合计划主任(Lawrence R. Wechsler,MD)反映了这些目标;一个咨询委员会,将成人和儿科神经病学临床医生和患者的专业知识和联络员纳入了咨询委员会;早期的调查员;和计划协调员。合作将通过定期见面并与提供者和社区开展。招聘将通过大批推荐提供者和社区宣传进行。效率和监控将通过使用中央IRB和标准化试验协议来实现;为每个试验建立时间表和基准;每月向共同投资者的下一个领导层报告;以及遇到挑战的纠正行动计划。在临床试验研究中促进职业将包括针对早期临床神经科学研究者的培训计划。匹兹堡大学医学中心在医疗保健领域的区域优势和这项创新提案的结合将使接下来的发展能够继续成为Neuronext网络中的模型网站,并有效地运行了将研究人员与社区提供者,患者和受训者整合在一起的临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paula R Clemens其他文献
Paula R Clemens的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paula R Clemens', 18)}}的其他基金
Vamorolone trial in Becker muscular dystrophy
贝克尔肌营养不良症的瓦莫洛龙试验
- 批准号:
10277734 - 财政年份:2021
- 资助金额:
$ 31.1万 - 项目类别:
Pilot Trial of Vamorolone for the Treatment of Becker Muscular Dystrophy
瓦莫洛龙治疗贝克尔肌营养不良症的初步试验
- 批准号:
10215387 - 财政年份:2020
- 资助金额:
$ 31.1万 - 项目类别:
Pilot Trial of Vamorolone for the Treatment of Becker Muscular Dystrophy
瓦莫洛龙治疗贝克尔肌营养不良症的初步试验
- 批准号:
10437669 - 财政年份:2020
- 资助金额:
$ 31.1万 - 项目类别:
Establishing a Cost-effective Return of Results to Parents of Boys in VISION-DMD Clinical Trials
在 VISION-DMD 临床试验中建立具有成本效益的结果返回给男孩父母
- 批准号:
9929267 - 财政年份:2019
- 资助金额:
$ 31.1万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)
神经科学临床试验卓越网络(匹兹堡大学 CRS)
- 批准号:
10742528 - 财政年份:2018
- 资助金额:
$ 31.1万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trials (University of Pittsburgh CRS)
神经科学临床试验卓越网络(匹兹堡大学 CRS)
- 批准号:
10604634 - 财政年份:2018
- 资助金额:
$ 31.1万 - 项目类别:
Phase IIa study of VBP15 for Duchenne muscular dystrophy
VBP15 治疗杜氏肌营养不良症的 IIa 期研究
- 批准号:
9047701 - 财政年份:2016
- 资助金额:
$ 31.1万 - 项目类别:
Pivotal trial of vamorolone in Duchenne muscular dystrophy
瓦莫龙治疗杜氏肌营养不良症的关键试验
- 批准号:
9767888 - 财政年份:2016
- 资助金额:
$ 31.1万 - 项目类别:
VBP15, an Innovative Steroid-like Intervention on DMD: VISION-DMD
VBP15,一种针对 DMD 的创新类固醇干预措施:VISION-DMD
- 批准号:
8960452 - 财政年份:2015
- 资助金额:
$ 31.1万 - 项目类别:
Becker muscular dystrophy: A natural history study to predict efficacy of exon sk
贝克尔肌营养不良症:预测外显子 sk 功效的自然史研究
- 批准号:
8102468 - 财政年份:2011
- 资助金额:
$ 31.1万 - 项目类别:
相似海外基金
The development of a systematic approach to harness real-world evidence for the evaluation of medication safety and effectiveness in children
开发一种系统方法来利用现实世界的证据来评估儿童用药的安全性和有效性
- 批准号:
10739628 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Assessment of a Radiomics-Based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules
基于放射组学的计算机辅助诊断工具对肺结节癌症风险分层的评估
- 批准号:
10644765 - 财政年份:2023
- 资助金额:
$ 31.1万 - 项目类别:
Tracheostomy and Laryngectomy Care: Virtual Reality Training for Health Professionals
气管切开术和喉切除术护理:针对健康专业人员的虚拟现实培训
- 批准号:
10409085 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Development of a comprehensive suite of research-backed, integrated educational tools to inspire, educate, train, and support academic entrepreneurs in the commercialization of university research.
开发一整套以研究为支持的综合教育工具,以激励、教育、培训和支持学术企业家将大学研究商业化。
- 批准号:
10547543 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别:
Clinical and Non-Invasive Biomarkers of Myotonic Dystrophy
强直性肌营养不良的临床和非侵入性生物标志物
- 批准号:
10524478 - 财政年份:2022
- 资助金额:
$ 31.1万 - 项目类别: